Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Bishop

Showing results (841-850 of 1,042) with videos related to

Pageof 105
Sort By:
Frontiers in Oncology|June 10, 2026
A phase 1 trial of HPV16 E7 T-cell receptor-engineered T cells in patients with relapsed/refractory HPV16-positive cancers (KITE-439 trial)Kedar Kirtane, Jiaxin Niu, George Blumenschein, et al.
Blood Advances|July 24, 2019
Tisagenlecleucel in relapsed/refractory diffuse large B-cell lymphoma patients without measurable disease at infusionMichael R Bishop, Richard T Maziarz, Edmund K Waller, et al.
Pediatric Blood & Cancer|November 15, 2019
Phase 1/2 trial of talazoparib in combination with temozolomide in children and adolescents with refractory/recurrent solid tumors including Ewing sarcoma: A Children's Oncology Group Phase 1 Consortium study (ADVL1411)Eric S Schafer, Rachel E Rau, Stacey L Berg, et al.
Molecular Genetics & Genomic Medicine|July 3, 2018
Establishment of the Alabama Hereditary Cancer Cohort - strategies for the inclusion of underrepresented populations in cancer genetics researchMadison R Bishop, Amit Shah, Melissa Shively, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 19, 2010
NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: report from the Committee on Disease-Specific Methods and Strategies for Monitoring Relapse following Allogeneic Stem Cell Transplantation. Part I: Methods, acute leukemias, and myelodysplastic syndromesNicolaus Kröger, Ulrike Bacher, Peter Bader, et al.
Geophysical Research Letters|October 1, 2020
Daytime Dynamo Electrodynamics With Spiral Currents Driven by Strong Winds Revealed by Vapor Trails and Sounding Rocket ProbesR Pfaff, M Larsen, T Abe, et al.
Schizophrenia Research|December 10, 2021
Real-time facial emotion recognition deficits across the psychosis spectrum: A B-SNIP StudyLeah H Rubin, Jiaxu Han, Jennifer M Coughlin, et al.
Biological Psychiatry|June 10, 2022
Regional and Sex-Specific Alterations in the Visual Cortex of Individuals With Psychosis Spectrum DisordersHalide Bilge Türközer, Paulo Lizano, Iniya Adhan, et al.
Blood Advances|April 25, 2022
Phase 1 study of CART-ddBCMA for the treatment of subjects with relapsed and refractory multiple myelomaMatthew J Frigault, Michael R Bishop, Jacalyn Rosenblatt, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 19, 2024
Safety concern of recombination between self-amplifying mRNA vaccines and viruses is mitigated in vivoTessy A H Hick, Corinne Geertsema, Wilson Nguyen, et al.
Pageof 105

Showing results (841-850 of 1,042) with videos related to

Sort By:
Pageof 105
Frontiers in Oncology|June 10, 2026
A phase 1 trial of HPV16 E7 T-cell receptor-engineered T cells in patients with relapsed/refractory HPV16-positive cancers (KITE-439 trial)Kedar Kirtane, Jiaxin Niu, George Blumenschein, et al.
Blood Advances|July 24, 2019
Tisagenlecleucel in relapsed/refractory diffuse large B-cell lymphoma patients without measurable disease at infusionMichael R Bishop, Richard T Maziarz, Edmund K Waller, et al.
Pediatric Blood & Cancer|November 15, 2019
Phase 1/2 trial of talazoparib in combination with temozolomide in children and adolescents with refractory/recurrent solid tumors including Ewing sarcoma: A Children's Oncology Group Phase 1 Consortium study (ADVL1411)Eric S Schafer, Rachel E Rau, Stacey L Berg, et al.
Molecular Genetics & Genomic Medicine|July 3, 2018
Establishment of the Alabama Hereditary Cancer Cohort - strategies for the inclusion of underrepresented populations in cancer genetics researchMadison R Bishop, Amit Shah, Melissa Shively, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 19, 2010
NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: report from the Committee on Disease-Specific Methods and Strategies for Monitoring Relapse following Allogeneic Stem Cell Transplantation. Part I: Methods, acute leukemias, and myelodysplastic syndromesNicolaus Kröger, Ulrike Bacher, Peter Bader, et al.
Geophysical Research Letters|October 1, 2020
Daytime Dynamo Electrodynamics With Spiral Currents Driven by Strong Winds Revealed by Vapor Trails and Sounding Rocket ProbesR Pfaff, M Larsen, T Abe, et al.
Schizophrenia Research|December 10, 2021
Real-time facial emotion recognition deficits across the psychosis spectrum: A B-SNIP StudyLeah H Rubin, Jiaxu Han, Jennifer M Coughlin, et al.
Biological Psychiatry|June 10, 2022
Regional and Sex-Specific Alterations in the Visual Cortex of Individuals With Psychosis Spectrum DisordersHalide Bilge Türközer, Paulo Lizano, Iniya Adhan, et al.
Blood Advances|April 25, 2022
Phase 1 study of CART-ddBCMA for the treatment of subjects with relapsed and refractory multiple myelomaMatthew J Frigault, Michael R Bishop, Jacalyn Rosenblatt, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 19, 2024
Safety concern of recombination between self-amplifying mRNA vaccines and viruses is mitigated in vivoTessy A H Hick, Corinne Geertsema, Wilson Nguyen, et al.
Pageof 105